MEDIROM Healthcare Technologies
MRM
5 hedge funds and large institutions have $67.8K invested in MEDIROM Healthcare Technologies in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
90% more capital invested
Capital invested by funds: $35.7K → $67.8K (+$32K)
67% more funds holding
Funds holding: 3 → 5 (+2)
0.53% more ownership
Funds ownership: 0.23% → 0.76% (+0.53%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$33.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$20.3K |
| 3 |
HF
HRT Financial
New York
|
+$17.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
-$6.01K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$3.29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $29.7K | +$33.3K | +22,932 | +634% |
|
|
TSS
2
Two Sigma Securities
New York
| $15.7K | +$20.3K | +13,977 | New |
|
|
HF
3
HRT Financial
New York
| $13K | +$17.3K | +11,905 | New |
|
|
GI
4
GAMMA Investing
Foster City,
California
| $7.18K | -$6.01K | -4,146 | -39% |
|
|
5
RhumbLine Advisers
Boston,
Massachusetts
| $2.22K | -$3.29K | -2,269 | -53% |
|
MRM Hedge Fund Activity: Q1 2026 in Review
5 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q1 2026, worth a combined $67.8K — up 90% from $35.7K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MRM positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $33.3K. The largest seller was GAMMA Investing, cutting an estimated $6.01K.
- 5 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q1 2026, up from 3 in Q4 2025.
- Funds reported $67.8K of MEDIROM Healthcare Technologies stock for Q1 2026, up 90% quarter-over-quarter.
- 2 funds opened new MEDIROM Healthcare Technologies positions in Q1 2026 and 0 closed out, a net change of +2 holders.
- The largest MEDIROM Healthcare Technologies buyer in Q1 2026 was UBS Group, an estimated $33.3K added.
- The largest MEDIROM Healthcare Technologies seller in Q1 2026 was GAMMA Investing, an estimated $6.01K sold.
Based on aggregated 13F filings for Q1 2026.